ACRO BIOMEDICAL CO., LTD. — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f8c7d321-e23d-4e9b-ba4c-283a27157e0f/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-154.0k | 2025-01-01 – 2025-12-31 | evidence 0001640334-26-000241 |
| FY 2024 | $-38.0k | 2024-01-01 – 2024-12-31 | evidence 0001640334-25-001300 |
| FY 2023 | $-8.8M | 2023-01-01 – 2023-12-31 | evidence 0001640334-25-001245 |
| FY 2022 | $-15.9M | 2022-01-01 – 2022-12-31 | evidence 0001640334-23-001347 |
| FY 2021 | $-7.7M | 2021-01-01 – 2021-12-31 | evidence 0001640334-22-000809 |
| FY 2020 | $-130.5k | 2020-01-01 – 2020-12-31 | evidence 0001640334-21-000767 |
| FY 2019 | $-422.8k | 2019-01-01 – 2019-12-31 | evidence 0001640334-21-000767 |
| FY 2018 | $515.5k | 2017-10-01 – 2018-09-30 | evidence 0001640334-18-002423 |
| FY 2017 | $-2.2k | 2016-10-01 – 2017-09-30 | evidence 0001640334-18-002423 |
| FY 2016 | $43.4k | 2015-10-01 – 2016-09-30 | evidence 0001640334-16-002238 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ACRO BIOMEDICAL CO., LTD. — all facts · Revenue · Net Income